Literature DB >> 24971423

The late effects of cancer and cancer treatment: a rapid review.

Charlene J Treanor1, Michael Donnelly.   

Abstract

This paper aims to synthesize literature about the definition, prevalence, onset and treatments associated with late effects. A rapid review was conducted using Google Scholar to identify reviews related to the late effects of adult-onset cancers. Papers were included if they provided a definition of late effects and/or presented a review of late effects as a result of adult-onset cancers in patients aged 18 years or older. Reviews related to nonmelanoma skin cancer were excluded. Reviews focusing on late effects in survivors of childhood-onset cancers (younger than 18 years) were ineligible for inclusion in the review. A total of 16 reviews were identified. Between 0% and 100% of survivors experienced a range of physical, psychological and social late effects. The onset of physical late effects was defined broadly as 'months or years' after treatment, whereas psychological late effects were defined as occurring at the end of treatment or similarly to physical late effects as 'months or years' after treatment. Few reviews provided an operational definition of late effects, and the onset of late effects was not often reported. Thus, reviews may have included the acute and long-term effects of cancer treatment. Evidence regarding causes, prevalence, and onset was incomplete for many late effects. Understanding the cause and onset of late effects is important in order to provide timely interventions to reduce the risk of late effect development in cancer patients.

Entities:  

Year:  2014        PMID: 24971423     DOI: 10.12788/jcso.0035

Source DB:  PubMed          Journal:  J Community Support Oncol        ISSN: 2330-7749


  9 in total

1.  Late effects of cancer and cancer treatment--the perspective of the patient.

Authors:  Charlene Treanor; Michael Donnelly
Journal:  Support Care Cancer       Date:  2015-06-13       Impact factor: 3.603

Review 2.  A methodological review of the Short Form Health Survey 36 (SF-36) and its derivatives among breast cancer survivors.

Authors:  Charlene Treanor; Michael Donnelly
Journal:  Qual Life Res       Date:  2014-08-20       Impact factor: 4.147

Review 3.  Quality of conduct and reporting in rapid reviews: an exploration of compliance with PRISMA and AMSTAR guidelines.

Authors:  Shannon E Kelly; David Moher; Tammy J Clifford
Journal:  Syst Rev       Date:  2016-05-10

4.  Title: Cervical cancer survivors' perceived cognitive complaints and supportive care needs in mainland China: a qualitative study.

Authors:  Yingchun Zeng; Andy Sk Cheng; Xiangyu Liu; Chetwyn Ch Chan
Journal:  BMJ Open       Date:  2017-06-22       Impact factor: 2.692

Review 5.  Meta-Analysis of the Effects of Neuropsychological Interventions on Cognitive Function in Non-Central Nervous System Cancer Survivors.

Authors:  Yingchun Zeng; Andy S K Cheng; Chetwyn C H Chan
Journal:  Integr Cancer Ther       Date:  2016-05-04       Impact factor: 3.279

6.  Effects of Acupuncture on Cancer-Related Cognitive Impairment in Chinese Gynecological Cancer Patients: A Pilot Cohort Study.

Authors:  Yingchun Zeng; Andy S K Cheng; Ting Song; Xiujie Sheng; Shaojing Wang; Jianfei Xie; Chetwyn C H Chan
Journal:  Integr Cancer Ther       Date:  2018-05-26       Impact factor: 3.279

Review 7.  Meta-Analysis of the Efficacy of Virtual Reality-Based Interventions in Cancer-Related Symptom Management.

Authors:  Yingchun Zeng; Jun-E Zhang; Andy S K Cheng; Huaidong Cheng; Jeffrey Scott Wefel
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

Review 8.  Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment.

Authors:  Charlene J Treanor; Una C McMenamin; Roisin F O'Neill; Chris R Cardwell; Mike J Clarke; Marie Cantwell; Michael Donnelly
Journal:  Cochrane Database Syst Rev       Date:  2016-08-16

9.  An international review and meta-analysis of prehabilitation compared to usual care for cancer patients.

Authors:  C Treanor; T Kyaw; M Donnelly
Journal:  J Cancer Surviv       Date:  2017-09-12       Impact factor: 4.442

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.